236 related articles for article (PubMed ID: 19585539)
1. Co-activator activator (CoAA) prevents the transcriptional activity of Runt domain transcription factors.
Li X; Hoeppner LH; Jensen ED; Gopalakrishnan R; Westendorf JJ
J Cell Biochem; 2009 Oct; 108(2):378-87. PubMed ID: 19585539
[TBL] [Abstract][Full Text] [Related]
2. Runt-related transcription factors impair activin induction of the follicle-stimulating hormone {beta}-subunit gene.
Breen KM; Thackray VG; Coss D; Mellon PL
Endocrinology; 2010 Jun; 151(6):2669-80. PubMed ID: 20357224
[TBL] [Abstract][Full Text] [Related]
3. The transcription factor Zbtb7b promotes CD4 expression by antagonizing Runx-mediated activation of the CD4 silencer.
Wildt KF; Sun G; Grueter B; Fischer M; Zamisch M; Ehlers M; Bosselut R
J Immunol; 2007 Oct; 179(7):4405-14. PubMed ID: 17878336
[TBL] [Abstract][Full Text] [Related]
4. Transcription factors Runx1 to 3 are expressed in the lacrimal gland epithelium and are involved in regulation of gland morphogenesis and regeneration.
Voronov D; Gromova A; Liu D; Zoukhri D; Medvinsky A; Meech R; Makarenkova HP
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3115-25. PubMed ID: 23532528
[TBL] [Abstract][Full Text] [Related]
5. RUNX3 interactome reveals novel centrosomal targeting of RUNX family of transcription factors.
Chuang LS; Lai SK; Murata-Hori M; Yamada A; Li HY; Gunaratne J; Ito Y
Cell Cycle; 2012 May; 11(10):1938-47. PubMed ID: 22544322
[TBL] [Abstract][Full Text] [Related]
6. TEThered to Runx: novel binding partners for runx factors.
Li X; Decker M; Westendorf JJ
Blood Cells Mol Dis; 2010 Jun; 45(1):82-5. PubMed ID: 20362478
[TBL] [Abstract][Full Text] [Related]
7. Inflammation-driven colon neoplasmatogenesis in uPA-deficient mice is associated with an increased expression of Runx transcriptional regulators.
Afaloniati H; Karagiannis GS; Hardas A; Poutahidis T; Angelopoulou K
Exp Cell Res; 2017 Dec; 361(2):257-264. PubMed ID: 29107070
[TBL] [Abstract][Full Text] [Related]
8. RUNX1 and RUNX2 upregulate Galectin-3 expression in human pituitary tumors.
Zhang HY; Jin L; Stilling GA; Ruebel KH; Coonse K; Tanizaki Y; Raz A; Lloyd RV
Endocrine; 2009 Feb; 35(1):101-11. PubMed ID: 19020999
[TBL] [Abstract][Full Text] [Related]
9. Lymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter.
Kahler RA; Westendorf JJ
J Biol Chem; 2003 Apr; 278(14):11937-44. PubMed ID: 12551949
[TBL] [Abstract][Full Text] [Related]
10. Runt domain factor (Runx)-dependent effects on CCAAT/ enhancer-binding protein delta expression and activity in osteoblasts.
McCarthy TL; Ji C; Chen Y; Kim KK; Imagawa M; Ito Y; Centrella M
J Biol Chem; 2000 Jul; 275(28):21746-53. PubMed ID: 10801838
[TBL] [Abstract][Full Text] [Related]
11. Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma.
Thomas DM; Johnson SA; Sims NA; Trivett MK; Slavin JL; Rubin BP; Waring P; McArthur GA; Walkley CR; Holloway AJ; Diyagama D; Grim JE; Clurman BE; Bowtell DD; Lee JS; Gutierrez GM; Piscopo DM; Carty SA; Hinds PW
J Cell Biol; 2004 Dec; 167(5):925-34. PubMed ID: 15583032
[TBL] [Abstract][Full Text] [Related]
12. The role for runt related transcription factor 2 (RUNX2) as a transcriptional repressor in luteinizing granulosa cells.
Park ES; Park J; Franceschi RT; Jo M
Mol Cell Endocrinol; 2012 Oct; 362(1-2):165-75. PubMed ID: 22713854
[TBL] [Abstract][Full Text] [Related]
13. Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors.
Lian JB; Javed A; Zaidi SK; Lengner C; Montecino M; van Wijnen AJ; Stein JL; Stein GS
Crit Rev Eukaryot Gene Expr; 2004; 14(1-2):1-41. PubMed ID: 15104525
[TBL] [Abstract][Full Text] [Related]
14. RUNX1 and RUNX2 transcription factors function in opposing roles to regulate breast cancer stem cells.
Fritz AJ; Hong D; Boyd J; Kost J; Finstaad KH; Fitzgerald MP; Hanna S; Abuarqoub AH; Malik M; Bushweller J; Tye C; Ghule P; Gordon J; Frietze S; Zaidi SK; Lian JB; Stein JL; Stein GS
J Cell Physiol; 2020 Oct; 235(10):7261-7272. PubMed ID: 32180230
[TBL] [Abstract][Full Text] [Related]
15. Core-binding factor beta interacts with Runx2 and is required for skeletal development.
Yoshida CA; Furuichi T; Fujita T; Fukuyama R; Kanatani N; Kobayashi S; Satake M; Takada K; Komori T
Nat Genet; 2002 Dec; 32(4):633-8. PubMed ID: 12434152
[TBL] [Abstract][Full Text] [Related]
16. The proto-oncoprotein SYT interacts with SYT-interacting protein/co-activator activator (SIP/CoAA), a human nuclear receptor co-activator with similarity to EWS and TLS/FUS family of proteins.
Perani M; Antonson P; Hamoudi R; Ingram CJ; Cooper CS; Garrett MD; Goodwin GH
J Biol Chem; 2005 Dec; 280(52):42863-76. PubMed ID: 16227627
[TBL] [Abstract][Full Text] [Related]
17. Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter.
Westendorf JJ; Zaidi SK; Cascino JE; Kahler R; van Wijnen AJ; Lian JB; Yoshida M; Stein GS; Li X
Mol Cell Biol; 2002 Nov; 22(22):7982-92. PubMed ID: 12391164
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent manner.
Jensen ED; Schroeder TM; Bailey J; Gopalakrishnan R; Westendorf JJ
J Bone Miner Res; 2008 Mar; 23(3):361-72. PubMed ID: 17997710
[TBL] [Abstract][Full Text] [Related]
19. Runt-related transcription factor 2 attenuates the transcriptional activity as well as DNA damage-mediated induction of pro-apoptotic TAp73 to regulate chemosensitivity.
Ozaki T; Sugimoto H; Nakamura M; Hiraoka K; Yoda H; Sang M; Fujiwara K; Nagase H
FEBS J; 2015 Jan; 282(1):114-28. PubMed ID: 25331851
[TBL] [Abstract][Full Text] [Related]
20. Identification of the GATA factor TRPS1 as a repressor of the osteocalcin promoter.
Piscopo DM; Johansen EB; Derynck R
J Biol Chem; 2009 Nov; 284(46):31690-703. PubMed ID: 19759027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
